CLINICAL_TRIALS
trial_result
· 2020-02-19
Clinical Trial Update: Safety and Tolerability of Risperidone Implants [Phase 3]
Summary
A Phase 3 trial update reports safety and tolerability data for risperidone implants in schizophrenia, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Braeburn Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2020-02-19